Karman Moves to Counter Bearish Concerns Ahead of Q3 'Clearing Event,' RBC Says
MT newswire2026/09/28 15:30Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
11:30 AM EDT, 09/28/2026 (MT Newswires) -- Karman Holdings (KRMN) has gone on the offensive to address a long list of concerns, and investors are likely to wait for Q3 results as a "clearing event," RBC Capital Markets said Sunday in a report. Karman's recent disclosures on margins, growth, acquisitions and working-capital efficiency are constructive, and the company is the best-positioned supplier in high-priority defense markets such as missiles, missile defense, space, hypersonics and maritime, RBC said. Concerns about second-sourcing and pricing pressure are overdone given the urgency to increase output across these programs, and Karman's post-IPO acquisitions are broadly in line with its roughly 30% margin profile, the report said. Karman shares have slumped this year amid abrupt management and auditor changes, short-seller reports, mixed messages on organic growth and a murky free-cash-flow outlook, RBC said. Recent stock weakness reflects investor caution ahead of US midterm elections and persistent concerns about cash generation, even as management guides to positive FCF in the H2, the report said. Q3 results are expected Nov. 5. RBC cut its price target on Karman stock to $70 from $85 and maintained its outperform rating. Price: 33.97, Change: -1.72, Percent Change: -4.82
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Why Bloom and AI Stocks Are Rising Despite OpenAI Safety Scare -- Barrons.com
Dow Jones•2026/09/29 12:34
FibroBiologics wins European patent for enhancing fibroblast therapeutic activity
Bitget•2026/09/29 12:32
BUZZ - Staar Surgical stock rises after Stifel upgrades rating to "Buy"
路透社•2026/09/29 12:31

Crypto prices
MoreBitcoin
BTC
$84,218.7
+1.12%
Ethereum
ETH
$2,735.52
+2.09%
Tether USDt
USDT
$0.9997
-0.00%
BNB
BNB
$764.99
-0.41%
XRP
XRP
$1.52
-0.02%
USDC
USDC
$1
+0.01%
Solana
SOL
$120.1
+0.52%
TRON
TRX
$0.3354
-0.06%
Zcash
ZEC
$1,441.37
-8.95%
Hyperliquid
HYPE
$88.4
-1.75%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now